Search Medical Condition
Please enter condition
Please choose location

Geneva, Switzerland Clinical Trials

A listing of Geneva, Switzerland clinical trials actively recruiting patients volunteers.

RESULTS

Found (79) clinical trials

Ultrasound Enhanced Thrombolytic Therapy of Middle Cerebral Artery Occlusion

Thrombolysis with intravenous(iv) tissue plasminogen activator (t-PA) is the only effective and approved therapy for acute ischemic stroke. The most frequent cause of ischemic stroke is thrombosis of the middle cerebral artery (MCA). Preliminary in vitro, animal and human studies suggest that ultrasound accelerates thrombolysis induced by t-PA, and recanalization ...

Phase

0.0 miles

Learn More »

Randomized Controlled Trial of Anticoagulation vs. Placebo for a First Symptomatic Isolated Distal Deep-vein Thrombosis (IDDVT)

The CACTUS-PTS study will compare anticoagulant treatment for 6 weeks versus placebo in acute, symptomatic distal DVT. Patients will be randomized to receive either a six-week period of LMWH at therapeutic dosage or a six-week period of placebo. All patients will be treated with elastic compression stockings and followed-up with ...

Phase

0.0 miles

Learn More »

Intravascular Ultrasound for Hepatocellular Carcinoma Staging

To diagnose hepatocellular carcinoma (HCC) and to determine the extent of the disease, a triphasic CT scan or a magnetic resonance imaging are required. The characterization of hepatic nodules is more difficult when the HCC lesions have a diameter of less than 2 cm. Since accuracy in the assessment of ...

Phase N/A

0.0 miles

Learn More »

A Study Measuring Quality of Life Treatment Preference and Satisfaction of ADPKD Patients in Europe

This is a prospective, non-interventional study (NIS) measuring health-related quality of life (HRQoL), treatment satisfaction, and other patient-reported outcomes (PROs) of ADPKD patients in Europe.

Phase N/A

0.0 miles

Learn More »

Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases:

The main objective of the PRECISESADS project is to reclassify the individuals affected by SADs into molecular clusters instead of clinical entities through the determination of molecular profiles using several "-omics" techniques. The specific objectives of this cross sectional study and sub-study are: 1. To identify a systemic taxonomy for ...

Phase N/A

0.0 miles

Learn More »

Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Inception Cohort

The overall objective of the PRECISESADS IMI project is to reclassify the individuals affected by SADs into clusters of molecular, instead of clinical entities through the determination of molecular profiles using several "-omics" techniques. The identification of the clusters relies on a cross sectional (CS) cohort/protocol where 2666 individuals (2000 ...

Phase N/A

0.0 miles

Learn More »

Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Case-control

The main objective of the PRECISESADS project is to reclassify the individuals affected by SADs into molecular clusters instead of clinical entities through the determination of molecular profiles using several "-omics" techniques. The specific objectives of this cross sectional study and sub-study are: 1. To identify a systemic taxonomy for ...

Phase N/A

0.0 miles

Learn More »

Impact of Specialised Renal Care in Patients With Chronic Kidney Disease

This is a prospective randomised trial studying patients with stage 3 to 5 chronic kidney disease (CKD) in order to determine the impact of specialised care by nephrologists compared to guidelines-directed management by primary care physicians (PCP) on: a) prognosis (clinical outcome), b) planning of renal replacement therapy (RRT) (urgent ...

Phase N/A

0.0 miles

Learn More »

Vascular Implant Safety and Efficacy Study

Assessment of the safety and clinical performance of a coronary stent system in de novo coronary artery lesions

Phase N/A

0.0 miles

Learn More »

Controlled Level EVERolimus in Acute Coronary Syndromes

Acute myocardial infarction (AMI) constitutes the major cause of death in most nations and death rates and morbidity remain substantial in the years thereafter. Inflammation is a hallmark throughout the distinct stages of atherosclerotic lesion formation preceding AMI as well as at the time of plaque rupture and during the ...

Phase

0.0 miles

Learn More »